Spesolimab in Pregnancy: A Breakthrough Treatment for Coexisting Generalized Pustular Psoriasis and Hallopeau Acrodermatitis Continua

Shi Yan, Ya Deng, Juan Gong

Open source

DOI
10.1097/mjt.0000000000002020
Published
2026-09
Container
American Journal of Therapeutics
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/mjt.0000000000002020,
  title = {Spesolimab in Pregnancy: A Breakthrough Treatment for Coexisting Generalized Pustular Psoriasis and Hallopeau Acrodermatitis Continua},
  author = {Shi Yan and Ya Deng and Juan Gong},
  year = {2026},
  journal = {American Journal of Therapeutics},
  doi = {10.1097/mjt.0000000000002020},
  url = {https://doi.org/10.1097/mjt.0000000000002020}
}

RIS

TY  - JOUR
TI  - Spesolimab in Pregnancy: A Breakthrough Treatment for Coexisting Generalized Pustular Psoriasis and Hallopeau Acrodermatitis Continua
AU  - Shi Yan
AU  - Ya Deng
AU  - Juan Gong
PY  - 2026
JO  - American Journal of Therapeutics
DO  - 10.1097/mjt.0000000000002020
UR  - https://doi.org/10.1097/mjt.0000000000002020
ER  - 

APA

Yan, S., Deng, Y., & Gong, J. (2026). Spesolimab in Pregnancy: A Breakthrough Treatment for Coexisting Generalized Pustular Psoriasis and Hallopeau Acrodermatitis Continua. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0000000000002020

Source records